albuterol has been researched along with Muscle Weakness in 10 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Muscle Weakness: A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Docking protein 7 (DOK7) congenital myasthenic syndrome (CMS) is characterized by limb-girdle weakness and lack of fluctuating fatigability simulating many familial myopathies." | 1.72 | Life-Long Steroid Responsive Familial Myopathy With Docking Protein 7 Mutation. ( King, PH; Oh, SJ; Schindler, A, 2022) |
| "This family needs to be reclassified as congenital myasthenic syndrome rather than congenital muscular dystrophy." | 1.39 | DOK7 limb-girdle myasthenic syndrome mimicking congenital muscular dystrophy. ( Abicht, A; Lochmüller, H; Mahjneh, I; Muntoni, F, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oh, SJ | 3 |
| King, PH | 3 |
| Schindler, A | 3 |
| McMacken, GM | 1 |
| Spendiff, S | 1 |
| Whittaker, RG | 1 |
| O'Connor, E | 1 |
| Howarth, RM | 1 |
| Boczonadi, V | 1 |
| Horvath, R | 1 |
| Slater, CR | 1 |
| Lochmüller, H | 2 |
| Delstanche, S | 1 |
| Servais, L | 1 |
| Gidaro, T | 1 |
| Caruso, JF | 1 |
| Hamill, JL | 1 |
| Yamauchi, M | 1 |
| Cook, TD | 1 |
| Mercado, DR | 1 |
| Wickel, EE | 1 |
| Somes, J | 1 |
| Donatelli, NS | 1 |
| Haran, M | 1 |
| Schattner, A | 1 |
| Mate, A | 1 |
| Starobin, D | 1 |
| Haran, G | 1 |
| Shtalrid, M | 1 |
| Mahjneh, I | 1 |
| Muntoni, F | 1 |
| Abicht, A | 1 |
| Restrepo, S | 1 |
| Haddad, S | 1 |
| Arabi, Y | 1 |
| Shimemeri, AA | 1 |
| Leatherman, JW | 1 |
| Fluegel, WL | 1 |
| David, WS | 1 |
| Davies, SF | 1 |
| Iber, C | 1 |
1 trial available for albuterol and Muscle Weakness
| Article | Year |
|---|---|
Albuterol and exercise effects on ankle extensor strength during 40 days of unloading.
Topics: Adrenergic beta-Agonists; Albuterol; Ankle; Exercise; Female; Humans; Male; Muscle Strength; Muscle | 2008 |
9 other studies available for albuterol and Muscle Weakness
| Article | Year |
|---|---|
Life-Long Steroid Responsive Familial Myopathy With Docking Protein 7 Mutation.
Topics: Albuterol; Humans; Male; Muscle Weakness; Mutation; Myasthenic Syndromes, Congenital; Steroids | 2022 |
Life-Long Steroid Responsive Familial Myopathy With Docking Protein 7 Mutation.
Topics: Albuterol; Humans; Male; Muscle Weakness; Mutation; Myasthenic Syndromes, Congenital; Steroids | 2022 |
Life-Long Steroid Responsive Familial Myopathy With Docking Protein 7 Mutation.
Topics: Albuterol; Humans; Male; Muscle Weakness; Mutation; Myasthenic Syndromes, Congenital; Steroids | 2022 |
Life-Long Steroid Responsive Familial Myopathy With Docking Protein 7 Mutation.
Topics: Albuterol; Humans; Male; Muscle Weakness; Mutation; Myasthenic Syndromes, Congenital; Steroids | 2022 |
Life-Long Steroid Responsive Familial Myopathy With Docking Protein 7 Mutation.
Topics: Albuterol; Humans; Male; Muscle Weakness; Mutation; Myasthenic Syndromes, Congenital; Steroids | 2022 |
Life-Long Steroid Responsive Familial Myopathy With Docking Protein 7 Mutation.
Topics: Albuterol; Humans; Male; Muscle Weakness; Mutation; Myasthenic Syndromes, Congenital; Steroids | 2022 |
Life-Long Steroid Responsive Familial Myopathy With Docking Protein 7 Mutation.
Topics: Albuterol; Humans; Male; Muscle Weakness; Mutation; Myasthenic Syndromes, Congenital; Steroids | 2022 |
Life-Long Steroid Responsive Familial Myopathy With Docking Protein 7 Mutation.
Topics: Albuterol; Humans; Male; Muscle Weakness; Mutation; Myasthenic Syndromes, Congenital; Steroids | 2022 |
Life-Long Steroid Responsive Familial Myopathy With Docking Protein 7 Mutation.
Topics: Albuterol; Humans; Male; Muscle Weakness; Mutation; Myasthenic Syndromes, Congenital; Steroids | 2022 |
Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.
Topics: Acetylcholinesterase; Adrenergic beta-Agonists; Agrin; Albuterol; Animals; Collagen; Disease Models, | 2019 |
Improved Muscular Weakness During Asthma Exacerbation.
Topics: Albuterol; Anti-Asthmatic Agents; Asthma; Diagnosis, Differential; Electromyography; Humans; Lordosi | 2017 |
A geriatric patient with medication-mediated profound weakness.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Anti-Arrhythmia Agents; Anticonvulsants; Antihyperte | 2010 |
Can a rare form of myasthenia gravis shed additional light on disease mechanisms?
Topics: Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Autoantibodies; Calcium Signaling; Carbon Dioxide; | 2013 |
DOK7 limb-girdle myasthenic syndrome mimicking congenital muscular dystrophy.
Topics: Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Diagnosis, Differential; Ephedrine; Female; H | 2013 |
New treatment alternatives for Duchenne and Becker muscular dystrophy.
Topics: Administration, Oral; Adrenergic beta-Agonists; Albuterol; Child; Child, Preschool; Clinical Trials | 2004 |
Hypokalemic paralysis mimicking Guillain-Barré syndrome and causing acute respiratory failure.
Topics: Acidosis, Respiratory; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Blood Gas Analysis; Diagn | 2004 |
Muscle weakness in mechanically ventilated patients with severe asthma.
Topics: Acute Disease; Adolescent; Adult; Aged; Albuterol; Asthma; Atracurium; Bronchodilator Agents; Cohort | 1996 |